Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes 
There is a need for novel biomarkers and better understanding of the pathophysiology of diabetic kidney disease.
Latest Published Articles
Abstract Context Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic glucocorticoid doses to suppress adrenocorticotropic hormone (ACTH) and control androgen excess. Nevanimibe hydrochloride (ATR-101), which selectively inhibits adrenal cortex function, might reduce androgen excess ...
Abstract Objective To describe the prevalence of and factors associated with different thyroid dysfunction phenotypes in women who are asymptomatic preconception. Design Observational cohort study. Setting A total of 49 hospitals across the United Kingdom between 2011 and 2016. Participants Women aged 16 to 41years with ...
Abstract Context Not all obese individuals develop cardiovascular disease (CVD). Hyperaldosteronism is suggested to cause inflammation and metabolic dysregulation, and might contribute to CVD development in obese individuals. Objective We aimed to investigate the association of aldosterone concentrations with inflammation, ...
Abstract Purpose To analyze the performance of basal 17OH-progesterone (17OHP) levels versus the basal 17OHP/cortisol ratio in nonclassical congenital adrenal hyperplasia (NCAH) and polycystic ovary syndrome (PCOS) differential diagnosis. Basal 17OHP levels >10 ng/mL have been used to confirm NCAH diagnosis without the ...
Abstract Context Serum expression of microRNAs (miRs) related to bone metabolism is affected by antiosteoporotic treatment. Objective To investigate the effect of sequential treatments on miR expression in postmenopausal women with osteoporosis. Design Observational, open label, nonrandomized clinical trial. Setting A ...
Abstract Context The associations between serum 25-hydroxyvitamin D concentrations [25(OH)D] and all-cause mortality have been inconsistent in existing literatures. One plausible reason is the interaction of intrinsic vitamin D with other biological conditions such as malnutrition and chronic inflammation. Objective To ...
“Our Response to COVID-19 as Endocrinologists and Diabetologists”
Read an editorial by JCEM Deputy Editors Ursula B Kaiser and Raghavendra G Mirmira, and JCEM EiC Paul M Stewart, on the global pandemic COVID-19.
Author Resource Center
The Endocrine Society provides its journal authors with a variety of tools and tips for increasing the discoverability and citation of their published work.
Preparing to submit? We work with American Journal Experts to provide editing, formatting, translation, and figure preparation services.
Format-Neutral Submission:
Submit new manuscripts as a single Word, RTF, or PDF file. Formatting not required until revision.
Sign up for Alerts
Register to receive table of contents email alerts as soon as new issues of JCEM are published online.
ORCiD
All submitting authors are required to provide an ORCiD (Open Researcher and Contributor ID) when uploading a manuscript. An author identification registry, ORCiD allows you to be uniquely identified with your work by eliminating name ambiguity. Register for free today!
Recommend to your library
Fill out our simple online form to recommend The Journal of Clinical Endocrinology & Metabolism to your library.
Committee on Publication Ethics
JCEM is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Submit
JCEM is the world’s leading peer-reviewed journal for endocrine clinical research and clinical practice. Article types include: original research, reviews, case reports, commentaries, and consensus statements. Submit your paper or preprint today.
